Boston


Connecting the dots.

The LEO Science & Tech Hub is the R&D innovation unit of LEO Pharma based in Boston, Tokyo, and Shanghai.

We explore cutting-edge science and technology opportunities that have the potential to enable precision medicine within Dermatology.

Leo Science & Techhub  |  © All Rights Reserved 2021

Discover how we work

Who are we?

Officially inaugurated in September 2016, LEO Science & Tech Hub pioneer dermatology with cutting-edge science, breakthrough technologies, and a deep understanding of skin diseases while empowering thought leaders and reinventing models in healthcare. By partnering with public and private institutions in the world’s leading life science cluster in Boston, we act as a catalyst to transform early-stage innovations and technologies into solutions that will improve the quality of life for people with skin diseases

LEO Science & Tech Hub – an R&D Innovation unit of LEO Pharma based in Boston, Tokyo, and Shanghai 

Pioneering dermatology with cutting-edge science, breakthrough technologies and a deep understanding of skin diseases while empowering thought leaders and reinventing models in healthcare

Our collaboration model

Our collaborations are based on robust science. We bring on board our scientific experts to discuss your potential research ideas.

Academic labs, Institution’s,  
Entrepreneurs, Start-ups, Venture Capitals
Ideas
Technologies
Assets
Talent
USA
Global R&D
Business
Development
Innovation
Lab
LEO
Foundation
Spin-outs/Spin-ins/VenturesExplore LEO Pharma’s assets outside dermatology
Leverage LEO Pharma’s
Dermatology expertise

we seek new paths of innovation

We open doors
to connect the dots

c

Precision medicine aims at identifying the most suitable treatment for each individual patient.

Precision Medicine in Dermatology

In order to achieve this, we will require a much deeper understanding of the different factors that contribute tothe course of disease between patients with the same disease, such as:

environmental

GENETICS

MOLECULAR

Environmental. Genetic. Molecular. Our current research projects aim at developing technologies that should enable us to adress these questions, resulting in solutions that can one day support treatment decisions.

News from Boston Hub

Latest news

Michael Sierra

Vice President of LEO Science & Tech Hub

+1 201 396 1810

michael.sierra@leo-scitech.com

Contact

We want to engage with partners who can help us develop innovative non-invasive and/or minimally invasive alternatives to skin biopsies. If you think your work could be relevant for us, please don’t hesitate to get in touch.

You are about to leave the LEO SCIENCE & TECH HUB website,
please click continue or cancel